Baker et al. Optum database study. Tofa assoc reduced incident RA-ILD. aHR 0.33 (vs ADA) @RheumNow #ACR22 Abstr#2251 #ACRbest https://t.co/R5rQ3KcHnq https://t.co/8Nq0t4zqQK

• Reduction in Rheumatoid Arthritis-Associated Interstitial Lung Disease Risk in …

#Vasculitis #ACR22 highlights. #Rituximab more remission in clinical care for GPA - observational, less infections if 600 mg IV fixed q6 mo how long to continue? Abst#1084 and less flares w Rituximab maintenance in the MAINRITSAN studies abst#527 Ritux is new SoC in GPA @RheumNow

Aggarwal @docrota et al. ProDERM results on skin and QoL. Statistically significant improvements in CDASI (both activity and damage) and SF-36. @RheumNow #ACR22 Abstr#2239 https://t.co/vsnvYUla13

• Effect of Treatment with IVIG (octagam10%) on Skin Symptoms and Quality of Life…

Let's review how GCs induce #Osteoporosis 👇(every Rheum should know this!) 💊GCs have bone cell specific effects on: 💠Osteoclasts ⬆️resorption, survival 💠Osteoblasts ⬇️🦴formation & prolif; ⬆️apoptosis 💠Osteocytes ⬆️apoptosis & skeletal fragility #ACR22 @RheumNow @rheumarhyme https://t.co/n61OXkmRgr

Espinosa-Ortega et al. Effect of DM ab on damage (as per MDI) over time. Most damage in PM/Scl>seronegative>other abs @RheumNow #ACR22 Abstr#2241 https://t.co/g8xTRyw6NZ https://t.co/sR1tT2QmU3

• Autoantibodies and Damage in Patients with Idiopathic Inflammatory Myopathies: …

BKZ resulted in clinically meaningful improvements in FACIT-Fatigue and pain (PtAAP) in approximately half of pts w/ active PsA who are bDMARD-naïve or TNFi-IR. Abs 2119 #ACR22 @RheumNow https://t.co/29gzmMZRlG https://t.co/qziqGNxQih

• Bimekizumab Treatment Results in Improvements in Fatigue and Pain in Biologic D…

After 1st TNFi, cycling/swapping strategies both acceptable in PsA w/ similar retention rates. Further studies needed to perform survival subgroup analysis regarding different extra-articular manifestations and PsA subtypes. Abs 2149 #ACR22 @RheumNow https://t.co/SRPhSiGeUI https://t.co/EYDULe52A3

• Cycling versus Swapping Strategies in Psoriatic Arthritis: Results from the Rhe…

Luedders et al. Higher plasma MMP-7 and MMP-9 assoc development incident RA-ILD in RA patients @RheumNow #ACR22 Abstr#2252 https://t.co/woVErubytC https://t.co/r916r1AxtN

• Higher Matrix Metalloproteinase Levels Are Predictive of Incident Interstitial …

More PsA pts on DEUC vs PBO achieved each of the MDA components at 16 weeks. Abs 2136 #ACR22 @RheumNow https://t.co/OrrDWfvGty https://t.co/CdCQzmgOOO

• Deucravacitinib, an Oral, Selective Tyrosine Kinase 2 Inhibitor, in a Phase 2 T…

🌟 COVAX register 🌟 🦠flares of IMRD following covid vax uncommon 👉factors associated with flare: ⬆️disease activity 🙋‍♀️ female 💊no DMARD @ vax 💊stop/⬇️ DMARD @ vax 👉⬇️ flare assoc with: 💥young 💉RTX @RheumNow #ACR22 Abst #2274 https://t.co/S892lKcEvS

Long term RZB provides durable efficacy response in PsA through 100 weeks. No new safety signals. Abs 2145 #ACR22 @RheumNow https://t.co/HfJvS1HzDW https://t.co/T67lDnxeLy

• Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Re…

Updated ACR GIOP guidelines: Panel recommends doing Initial fracture risk assessment using the CLINICAL fracture risk assessment then RE-assessing while pts continue on GCs (👇) ☝️Magic nos. GC>/= 2.5mg/d for >3mos #ACR22 @RheumNow @rheumarhyme #Osteoporosis https://t.co/7oWqHg8Tdv

Connolly @CaoilfhionnMD et al. 3 doses SARS-CoV-2 vaccine assoc reduced breakthrough infection in Omicron wave in RMD patients. @RheumNow #ACR22 Abstr#2275 https://t.co/ONXiY8JShK https://t.co/QHNYG9XuJ0

• Three Dose SARS-CoV-2 Vaccination Is Associated with Reduced Risk of Breakthrou…

Wilson et al. Sputum levels of TGF-β1, TNF-α, MCP-1, and IL-4 are significantly elevated in RA-ILD and a portion of these cytokines are also increased in subclinical disease and correlated with lung physiology @RheumNow #ACR22 Abstr#2253 https://t.co/V1fG0QC9od https://t.co/d2YvVIV3Jq

• Sputum Cytokines Are Elevated in Rheumatoid Arthritis-Associated Interstitial L…

Should You Repeat the ENA Panel? Dr. Kathryn Dao ( @KDAO2011) discusses abstract 0725, presented at #ACR22 Convergence. Abstract 0725: Utility of Repeat Extractable Nuclear Antigen Antibody Testing- a Retrospective Audit https://t.co/6A2ksN6yC2 https://t.co/U62Ab7jj3d

• https://bit.ly/3O9wYMe